{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:05:53Z","timestamp":1649088353889},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T00:00:00Z","timestamp":1273104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s11934-010-0118-4","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T03:35:25Z","timestamp":1273030525000},"page":"265-270","source":"Crossref","is-referenced-by-count":5,"title":["A Review of Botulinum Toxcin Use for Chronic Pelvic Pain Syndrome"],"prefix":"10.1007","volume":"11","author":[{"given":"Henry P.","family":"Gottsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,6]]},"reference":[{"key":"118_CR1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0090-4295(03)00583-1","volume":"62","author":"JC Nickel","year":"2003","unstructured":"Nickel JC, Downey J, Clark J, et al.: Levofloxacin for chronic prostatitis\/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 2003, 62:614\u2013617.","journal-title":"Urology"},{"key":"118_CR2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1464-410X.2007.06667.x","volume":"99","author":"SM Bates","year":"2007","unstructured":"Bates SM, Hill VA, Anderson JB, et al.: A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis\/chronic pelvic pain syndrome. BJU Int 2007, 99:355\u2013359.","journal-title":"BJU Int"},{"key":"118_CR3","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1056\/NEJMoa0803240","volume":"359","author":"JC Nickel","year":"2008","unstructured":"Nickel JC, Krieger JN, McNaughton-Collins M, et al.: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 2008, 359:2663\u20132673.","journal-title":"N Engl J Med"},{"key":"118_CR4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11934-008-0057-5","volume":"9","author":"C Kastner","year":"2008","unstructured":"Kastner C: Update on minimally invasive therapy for chronic prostatitis\/chronic pelvic pain syndrome. Curr Urol Rep 2008, 9:333\u2013338.","journal-title":"Curr Urol Rep"},{"key":"118_CR5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2005.03.008","volume":"128","author":"MA Pezzone","year":"2005","unstructured":"Pezzone MA, Liang R, Fraser MO: A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology 2005, 128:1953\u20131964.","journal-title":"Gastroenterology"},{"key":"118_CR6","doi-asserted-by":"crossref","unstructured":"Yilmaz U, Liu YW, Berger RE, Yang CC: Autonomic nervous system changes in men with chronic pelvic pain syndrome. J Urol 2007, 177:2170\u20132174; discussion 2174.","DOI":"10.1016\/j.juro.2007.01.144"},{"key":"118_CR7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000138962","volume":"60","author":"M Eisa","year":"2008","unstructured":"Eisa M, Singer C, Sengun C, et al.: Treatment of painful limbs\/moving extremities with botulinum toxin type A injections. Eur Neurol 2008, 60:104\u2013106.","journal-title":"Eur Neurol"},{"key":"118_CR8","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/01.wnl.0000311390.87642.d8","volume":"70","author":"M Naumann","year":"2008","unstructured":"Naumann M, So Y, Argoff CE, et al.: Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008, 70:1707\u20131714.","journal-title":"Neurology"},{"key":"118_CR9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncpuro1124","volume":"5","author":"MB Chancellor","year":"2008","unstructured":"Chancellor MB, Fowler CJ, Apostolidis A, et al.: Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol 2008, 5:319\u2013328.","journal-title":"Nat Clin Pract Urol"},{"key":"118_CR10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.toxicon.2009.01.040","volume":"54","author":"MR Baldwin","year":"2009","unstructured":"Baldwin MR, Barbieri JT: Association of botulinum neurotoxins with synaptic vesicle protein complexes. Toxicon 2009, 54:570\u2013574.","journal-title":"Toxicon"},{"key":"118_CR11","doi-asserted-by":"crossref","unstructured":"Coelho A, Dinis P, Pinto R, et al.: Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder. Eur Urol 2009 Dec 29 [Epub ahead of print].","DOI":"10.1016\/S1569-9056(09)60228-1"},{"key":"118_CR12","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","volume":"169","author":"CP Smith","year":"2003","unstructured":"Smith CP, Franks ME, McNeil BK, et al.: Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 2003, 169:1896\u20131900.","journal-title":"J Urol"},{"key":"118_CR13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","volume":"45","author":"M Khera","year":"2004","unstructured":"Khera M, Somogyi GT, Kiss S, et al.: Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 2004, 45:987\u2013993.","journal-title":"Neurochem Int"},{"key":"118_CR14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1464-410X.2004.04858.x","volume":"93","author":"HV Tempest","year":"2004","unstructured":"Tempest HV, Dixon AK, Turner WH, et al.: P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 2004, 93:1344\u20131348.","journal-title":"BJU Int"},{"key":"118_CR15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","volume":"38","author":"MJ Welch","year":"2000","unstructured":"Welch MJ, Purkiss JR, Foster KA: Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000, 38:245\u2013258.","journal-title":"Toxicon"},{"key":"118_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-6-12","volume":"6","author":"YC Chuang","year":"2006","unstructured":"Chuang YC, Tu CH, Huang CC, et al.: Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs. BMC Urol 2006, 6:12.","journal-title":"BMC Urol"},{"key":"118_CR17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.juro.2007.07.120","volume":"180","author":"YC Chuang","year":"2008","unstructured":"Chuang YC, Yoshimura N, Huang CC, et al.: Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J Urol 2008, 180:742\u2013748.","journal-title":"J Urol"},{"key":"118_CR18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(05)79580-5","volume":"352","author":"G Maria","year":"1998","unstructured":"Maria G, Destito A, Lacquaniti S, et al.: Relief by botulinum toxin of voiding dysfunction due to prostatitis. Lancet 1998, 352:625.","journal-title":"Lancet"},{"key":"118_CR19","doi-asserted-by":"crossref","unstructured":"Maria G, Brisinda G, Civello IM, et al:. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 2003, 62:259\u2013264; discussion 264\u2013265.","DOI":"10.1016\/S0090-4295(03)00477-1"},{"key":"118_CR20","doi-asserted-by":"crossref","unstructured":"Chuang YC, Chiang PH, Yoshimura N, et al.: Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia. BJU Int 2006, 98:1033\u20131037; discussion 1337.","DOI":"10.1111\/j.1464-410X.2006.06479.x"},{"key":"118_CR21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.urology.2005.04.029","volume":"66","author":"YC Chuang","year":"2005","unstructured":"Chuang YC, Chiang PH, Huang CC, et al.: Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology 2005, 66:775\u2013779.","journal-title":"Urology"},{"key":"118_CR22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.urology.2004.10.077","volume":"65","author":"HC Kuo","year":"2005","unstructured":"Kuo HC: Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates. Urology 2005, 65:670\u2013674.","journal-title":"Urology"},{"key":"118_CR23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/00365590902811537","volume":"43","author":"HC Kuo","year":"2009","unstructured":"Kuo HC, Liu HT: Therapeutic effects of add-on botulinum toxin A on patients with large benign prostatic hyperplasia and unsatisfactory response to combined medical therapy. Scand J Urol Nephrol 2009, 43:206\u2013211.","journal-title":"Scand J Urol Nephrol"},{"key":"118_CR24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000020314","volume":"38","author":"D Zermann","year":"2000","unstructured":"Zermann D, Ishigooka M, Schubert J, Schmidt RA: Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 2000, 38:393\u2013399.","journal-title":"Eur Urol"},{"issue":"4 Suppl","key":"118_CR25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-5347(18)32371-1","volume":"175","author":"SM Shin","year":"2006","unstructured":"Shin SM, Park DS: Multi-regional injections of low-dose botulinum toxin A for men with chronic pelvic pain syndrome [abstract 104]. J Urol 2006, 175(4 Suppl):34.","journal-title":"J Urol"},{"key":"118_CR26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00120-007-1384-8","volume":"46","author":"T Bschleipfer","year":"2007","unstructured":"Bschleipfer T, Wagenlehner FM, Weidner W: [Intraprostatic botulinum toxin A injection in chronic prostatitis and chronic pelvic pain syndrome (CP\/CPPS)] [in German]. Urologe A 2007, 46:1030\u20131032.","journal-title":"Urologe A"},{"key":"118_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-5347(05)65399-2","volume":"167","author":"A Mehik","year":"2002","unstructured":"Mehik A, Hellstrom P, Nickel JC, et al.: The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol 2002, 167:137\u2013140.","journal-title":"J Urol"},{"key":"118_CR28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0090-4295(99)80048-X","volume":"45","author":"JL Miller","year":"1995","unstructured":"Miller JL, Rothman I, Bavendam TG, Berger RE: Prostatodynia and interstitial cystitis: one and the same? Urology 1995, 45:587\u2013590.","journal-title":"Urology"},{"key":"118_CR29","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0022-5347(06)00629-X","volume":"175","author":"P Abrams","year":"2006","unstructured":"Abrams P, Baranowski A, Berger RE, et al.: A new classification is needed for pelvic pain syndromes: are existing terminologies of spurious diagnostic authority bad for patients? J Urol 2006, 175:1989\u20131990.","journal-title":"J Urol"},{"key":"118_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eururo.2007.10.010","volume":"53","author":"AP Baranowski","year":"2008","unstructured":"Baranowski AP, Abrams P, Berger RE, et al.: Urogenital pain: time to accept a new approach to phenotyping and, as a consequence, management. Eur Urol 2008, 53:33\u201336.","journal-title":"Eur Urol"},{"key":"118_CR31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.juro.2007.10.032","volume":"179","author":"A Giannantoni","year":"2008","unstructured":"Giannantoni A, Porena M, Costantini E, et al.: Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol 2008, 179:1031\u20131034.","journal-title":"J Urol"},{"key":"118_CR32","doi-asserted-by":"crossref","unstructured":"\u2022 Kuo HC, Chancellor MB: Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome. BJU Int 2009, 104:657\u2013661. This is a randomized controlled trial of botulinum toxin versus standard therapy for IC\/PBS in a mixed cohort with improved symptoms.","DOI":"10.1111\/j.1464-410X.2009.08495.x"},{"key":"118_CR33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.urology.2007.04.038","volume":"70","author":"HT Liu","year":"2007","unstructured":"Liu HT, Kuo HC: Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 2007, 70:463\u2013468.","journal-title":"Urology"},{"key":"118_CR34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1464-410X.2008.07740.x","volume":"102","author":"YC Chuang","year":"2008","unstructured":"Chuang YC, Kim DK, Chiang PH, Chancellor MB: Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. BJU Int 2008, 102:704\u2013706.","journal-title":"BJU Int"},{"key":"118_CR35","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/mus.21001","volume":"38","author":"MM Roberts","year":"2008","unstructured":"Roberts MM: Neurophysiology in neurourology. Muscle Nerve 2008, 38:815\u2013836.","journal-title":"Muscle Nerve"},{"key":"118_CR36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-5347(01)64018-7","volume":"159","author":"RE Berger","year":"1998","unstructured":"Berger RE, Miller JE, Rothman I, et al.: Bladder petechiae after cystoscopy and hydrodistension in men diagnosed with prostate pain. J Urol 1998, 159:83\u201385.","journal-title":"J Urol"},{"key":"118_CR37","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.45.4.712","volume":"45","author":"MA Grazko","year":"1995","unstructured":"Grazko MA, Polo KB, Jabbari B: Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995, 45:712\u2013717.","journal-title":"Neurology"},{"key":"118_CR38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.AOG.0000237100.29870.cc","volume":"108","author":"JA Abbott","year":"2006","unstructured":"Abbott JA, Jarvis SK, Lyons SD, et al.: Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol 2006, 108:915\u2013923.","journal-title":"Obstet Gynecol"},{"key":"118_CR39","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1365-2036.2009.03964.x","volume":"29","author":"SS Rao","year":"2009","unstructured":"Rao SS, Paulson J, Mata M, Zimmerman B: Clinical trial: effects of botulinum toxin on Levator ani syndrome--a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2009, 29:985\u2013999.","journal-title":"Aliment Pharmacol Ther"},{"key":"118_CR40","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.ju.0000080513.13968.56","volume":"170","author":"DC Hetrick","year":"2003","unstructured":"Hetrick DC, Ciol MA, Rothman I, et al.: Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case-control study. J Urol 2003, 170:828\u2013831.","journal-title":"J Urol"},{"key":"118_CR41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.juro.2007.09.088","volume":"179","author":"DA Shoskes","year":"2008","unstructured":"Shoskes DA, Berger R, Elmi A, et al.: Muscle tenderness in men with chronic prostatitis\/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J Urol 2008, 179:556\u2013560.","journal-title":"J Urol"},{"key":"118_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2490-7-17","volume":"7","author":"RE Berger","year":"2007","unstructured":"Berger RE, Ciol MA, Rothman I, Turner JA: Pelvic tenderness is not limited to the prostate in chronic prostatitis\/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP\/CPPS. BMC Urol 2007, 7:17.","journal-title":"BMC Urol"},{"key":"118_CR43","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Fitzgerald MP, Anderson RU, Potts J, et al.: Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 2009, 182:570\u2013580. This is a pilot randomized controlled trial of massage versus pelvic floor physical therapy in men and women with pelvic pain.","DOI":"10.1016\/j.juro.2009.04.022"},{"issue":"Suppl 4","key":"118_CR44","first-page":"405","volume":"183","author":"HP Gottsch","year":"2010","unstructured":"Gottsch HP, Berger RE, Miller JL, Yang CC: Pelvic floor injection of botulinum toxin a for pelvic pain: a randomized, controlled pilot study [abstract 1041]. J Urol 2010, 183(Suppl 4):405.","journal-title":"J Urol"},{"key":"118_CR45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1525-1497.2005.0247.x","volume":"20","author":"M Plews-Ogan","year":"2005","unstructured":"Plews-Ogan M, Owens JE, Goodman M, et al.: A pilot study evaluating mindfulness-based stress reduction and massage for the management of chronic pain. J Gen Intern Med 2005, 20:1136\u20131138.","journal-title":"J Gen Intern Med"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-010-0118-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-010-0118-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-010-0118-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:52:10Z","timestamp":1559436730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-010-0118-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,6]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1007\/s11934-010-0118-4","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,6]]}}}